On October 17, 2012, CRI held its 26th Annual Awards Dinner at the Waldorf Astoria in New York, where we honored exemplary individuals whose scientific and civic contributions have helped advance cancer research and treatment.
The 2012 William B. Coley Award, CRI’s highest scientific honor, was presented to Richard A. Flavell, Ph.D., FRS, Laurie H. Glimcher, M.D., and Kenneth M. Murphy, M.D., Ph.D., for their pioneering work to define the transcription factors that regulate CD4+ T cell differentiation, and to Carl H. June, M.D., and Michel Sadelain, M.D., Ph.D., for their groundbreaking work on the development of chimeric antigen receptor (CAR) T cell therapy for cancer.
CRI also presented the 2012 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research to Mark Frissora, chairman and CEO of The Hertz Corporation, for his company’s philanthropic support of cancer care and research through CRI and other charities, and to Severin Schwan, CEO of Roche, in honor of Roche’s dedication to personalized healthcare, including immune-based therapies, for cancer. More than 200 guests attended the event, which raised $665,000 for the Institute.
Co-chairs and presenters at the event were Dr. James P. Allison, Dr. Mike Burgess, John Fitzgibbons,Don Gogel, Dr. Mitchell Gold, Dr. Hy Levitsky, Paul Sekhri, Paul Shiverick, Dr. Jedd Wolchok, and Jenna Wolfe, co-anchor, Sunday edition of Weekend TODAY, and TODAY correspondent, serviced as master of ceremonies.
Read the press release here.
Photos from the event are can be seen here.
All images copyright by Cancer Research Institute.
Photography credit: Barbara Nitke.